InVitro International, Inc. IVRO
OTC PK
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.27M | ||||
| Total Receivables | 68.10K | ||||
| Inventory | 179.20K | ||||
| Prepaid Expenses | 40.00K | ||||
| Finance Division Loans and Leases Current | -- | ||||
| Total Finance Division Other Current Assets | -- | ||||
| Other Current Assets | -- | ||||
| Total Current Assets | 1.55M | ||||
|
|
|||||
| Total Current Assets | 1.55M | ||||
| Net Property, Plant & Equipment | 332.40K | ||||
| Long-term Investments | -- | ||||
| Goodwill | -- | ||||
| Total Other Intangibles | 6.30K | ||||
| Finance Div Loans & Leases LT | -- | ||||
| Total Finance Div Other LT Assets | -- | ||||
| Total Other Assets | 70.00K | ||||
| Total Assets | 1.96M | ||||
|
|
|||||
| Total Accounts Payable | 200.00 | ||||
| Total Accrued Expenses | 30.30K | ||||
| Short-term Debt | -- | ||||
| Current Portion of Long-Term Debt/Capital Leases | -- | ||||
| Finance Division Debt Current | 55.50K | ||||
| Total Finance Division Other Current Liabilities | 800.00 | ||||
| Total Other Current Liabilities | 800.00 | ||||
| Total Current Liabilities | 86.80K | ||||
|
|
|||||
| Total Current Liabilities | 86.80K | ||||
| Long-Term Debt | -- | ||||
| Short-term Debt | -- | ||||
| Capital Leases | 271.70K | ||||
| Finance Division Debt Non Current | -- | ||||
| Total Finance Division Other Non Current Liabilities | -- | ||||
| Total Other Liabilities | -- | ||||
| Total Liabilities | 358.50K | ||||
|
|
|||||
| Common Stock & APIC | 682.30K | ||||
| Retained Earnings | 856.60K | ||||
| Treasury Stock & Other | 64.00K | ||||
| Total Common Equity | 1.60M | ||||
|
|
|||||
| Preferred Stock Redeemable | -- | ||||
| Preferred Stock Non Redeemable | -- | ||||
| Preferred Stock Convertible | -- | ||||
| Preferred Stock, Others | -- | ||||
| Total Preferred Equity | -- | ||||
|
|
|||||
| Total Common Equity | 1.60M | ||||
| Total Preferred Equity | -- | ||||
| Total Minority Interest | -- | ||||
| Total Equity | 1.60M | ||||
|
|
|||||